|
NHERF-1 Protein Complexes, Cancer Progression and Therapeutic Targeting
Researchers at TGen have patented a method of detecting invasive glioblastoma in a subject and sensitizing the subject to a therapeutic treatment that targets non-migrating glioblastoma cells. Specifically, our researchers have discovered that Na+/H+ exchanger regulatory factor (NHERF-1) is over-expressed in invasive GBM cells and have confirmed its...
Published: 1/11/2024
|
Inventor(s): Michael Berens, Kerri Kislin
Keywords(s): Cancer & Cell Biology
Category(s): Therapeutics, Diagnostics
|
